Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The most exciting exoplanet discoveries of 2025 - 2South America's Memorable Destinations: A Movement Guide
- 3'Stranger Things' Season 5: When does Volume 2 come out? And Volume 3? Everything to know about the remaining episodes before the finale.
- 4The 10 Most Famous Works of art Ever
- 5New York to require social media platforms to display mental health warnings
- The Specialty of Compromise: Examples from Reality
- Cuba says 33 have died of mosquito-borne illnesses as epidemic rages
- Building a Flourishing Business: Illustrations from Business people
- Experience Arranging: Planning for Epic Excursions
- Turkey key underlying issue as Israel, Greece, Cyprus hold summit
- The 15 Best Business visionaries Under 40
- Shipping: The Corridors of Trade and the Coming of Another Period
- Exhaustive Experiences into Prudent Senior Living in the UK
- This Unique National Park In Canada Is Famous For Its Otherworldly Limestone Monoliths
